Observing brain blood flow changes in neurosurgical patients
Official title: Longitudinal Investigation of Brain Blood Flow Changes in Neurosurgical Patients
Run by University of Zurich · NCT04668261 · Data updated 2026-11-12
This study looks at how blood flow in the brain changes over time in neurosurgery patients compared to those who don’t have surgery and healthy people, to see if these changes can help us understand brain health better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | University of Zurich Academic / other |
| Locations | 1 site (Zurich) |
| Status | Recruiting |
| Started | January 1, 2021 |
| Main results expected | November 1, 2025 |
| Study ends | November 1, 2027 |
| Registry record updated | December 29, 2020 |
| Trial ID | NCT04668261 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 with neurosurgical diseases such as cerebrovascular disease, brain tumors, or normal pressure hydrocephalus.
✕Probably not a fit
Patients with respiratory or cardiac limitations that prevent participation in breathing maneuvers may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to longitudinally observe changes in brain blood flow among neurosurgical patients, comparing those who undergo surgical interventions with those receiving conservative treatment, as well as a healthy cohort. It will evaluate the relationship between hemodynamic patterns and structural brain tissue changes over time. The study seeks to identify novel imaging biomarkers that could enhance understanding of brain blood flow dynamics in relation to neurosurgical conditions.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and treatment strategies for patients with brain blood flow impairments.
How similar studies have gone: While this approach is observational, similar studies have shown promise in understanding brain hemodynamics, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria Patients: * Male and Female subjects \>18 years of age * Written informed consent after participants' information. Foreign speaking patients should be accompanied by a person with sufficient German language proficiency to act as a translator * Neurosurgical diseases with the potential to alter blood flow to the brain: * Cerebrovascular disease * Brain tumors * Normal Pressure Hydrocephalus Healthy subjects: * Male and Female subjects \>18 years of age * Written Informed Consent by the participant after information about the project. Foreign speaking healthy subjects should be accompanied by a person with sufficient German language proficiency to act as a translator Exclusion criteria: Patients: * Unwilling or unable to co-operate with breathing maneuvers * Respiratory or cardiac limitations to breathing through a mask * Medical contra-indications to limited hypercapnia (high CO2 - 50 mmHg) or hypocapnia (low CO2 - 30 mmHg) (i.e., known increased intracerebral pressure, metabolic acidosis or alkalosis) * Standard contraindications for MRI scanning * Verbal confirmed pregnancy * Known multiple intracranial diseases * Presence of intracranial hemorrhage within the last 3 months * Symptomatic increased intracranial pressure Healthy subjects: * Unwilling or unable to co-operate with breathing maneuvers * Respiratory or cardiac limitations to breathing through a mask * Medical contra-indications to limited hypercapnia (high CO2 - 50 mmHg) or hypocapnia (low CO2 - 30 mmHg) (i.e., known increased intracerebral pressure, metabolic acidosis or alkalosis) * Standard contraindications for MRI scanning * Verbal confirmed pregnancy * Anamnesticly a history of neurological disease or current neurological deficits.
Where it's running
-
University Hospital Zurich
Zurich, Switzerland Recruiting
Study contacts
- Study coordinator: Jorn Fierstra, MD, PhD
- Email: jorn.fierstra@usz.ch
- Phone: 0041 442553169
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Long-term outcomes after vacuum-induced tamponade for postpartum hemorrhage
This study will look at women who had postpartum hemorrhage treated with vacuum-induced tamponade at a Zurich hospital to see how they fared over time, including future pregnancies and fertility.
-
Add-on Sildenafil Before Exercise in PAH to See if Max Workload Improves
This study tests whether taking 20 mg sildenafil right before exercise helps people with pulmonary arterial hypertension perform more work during cardiopulmonary testing.
-
Fatigue Investigation Using Digital Outcomes
This study tests whether digital monitoring with a smartphone app and wearables can track fatigue in people with MS or long COVID, compared with healthy volunteers.
-
Impact of ambient air vs nasal liquid oxygen on exercise performance in pulmonary vascular disease
This study tests whether using nasal liquid oxygen during a 6-minute walk test changes how far patients with PAH or CTEPH can walk compared to breathing room air.
-
Liquid oxygen vs ambient air during a 6-minute walk in people with pulmonary vascular disease
This study tests whether walking with liquid oxygen at about 4 L/min helps or hinders distance walked compared with walking on room air in adults with PAH or CTEPH living in Switzerland.
-
Daily adjustment of radiation dose in MRI-guided SBRT for abdominal and pelvic tumors
This trial tests whether adjusting the radiation dose in real-time during MRI-guided SBRT improves targeting for abdominal or pelvic tumors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.